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EpsinR is a clathrin-coated vesicle (CCV)-associated protein that binds to vti1b, suggesting that it may be a vti1b-selective
adaptor. Depletion of epsinR to undetectable levels in HeLa cells using siRNA causes vti1b to redistribute from the
perinuclear region to the cell periphery, but vti1a also redistributes in epsinR-depleted cells, and both vti isoforms
redistribute in AP-1–depleted cells. As a more direct assay for epsinR function, we isolated CCVs from control and
siRNA-treated cells and then looked for differences in cargo content. In clathrin-depleted cells, both coat and cargo
proteins are greatly reduced in this preparation. Knocking down epsinR causes a 50% reduction in the amount of AP-1
copurifying with CCVs and vice versa, indicating that the two proteins are dependent on each other for maximum
incorporation into the coat. In addition, vti1b, but not vti1a, is reduced by >70% in CCVs from both epsinR- and
AP-1–depleted cells. Because AP-1 knockdown reduces the amount of epsinR in CCVs, it is possible that its effect on vti1b
may be indirect. These findings provide in vivo evidence that epsinR is an adaptor for vti1b, and they also show that CCV
isolation can be used as an assay for adaptor function.
INTRODUCTION
Transport vesicles contain many different types of cargo
proteins, but none are more important than the SNAREs,
because without SNAREs the vesicles would be unable to
fuse with the target membrane. To get packaged into
vesicles, cargo proteins must contain specific sorting sig-
nals that interact with components of the vesicle coat. For
instance, tyrosine- and dileucine-based motifs (YXX and
[D/E]XXXL[L/I]) interact with adaptor protein (AP) com-
plexes such as AP-1 and AP-2, which are associated with
clathrin-coated vesicles (CCVs) budding from TGN/en-
dosomal membranes and from the plasma membrane,
respectively (Bonifacino and Traub, 2003). However, with
the exception of VAMP4, which contains a dileucine motif
and binds to AP-1 (Peden et al., 2001), most of the SNAREs
that are packaged into CCVs lack defined sorting signals.
Although AP-1 and AP-2 were originally assumed to be
the only cargo adaptors for clathrin-mediated trafficking,
recent studies suggest that, at least at the plasma membrane,
there are other, more minor adaptors that select cargo pro-
teins lacking binding sites for AP-2. These cargo-selective
adaptors all bind to the appendage or “ear” domains of the
large subunits of the AP-2 complex, and they also all interact
with clathrin, with PIP2, which helps to target them to the
plasma membrane, and with different types of internaliza-
tion signals. For instance, the epsins have ubiquitin-interact-
ing motifs, which may facilitate the internalization of ubi-
quitinated cargo proteins such as activated growth factor
receptors. Dab2 and ARH are two cargo-selective adaptors
that bind to sorting signals found in members of the LDL
receptor family (Traub, 2003). We have recently shown that
these adaptors can function even in the absence of any
detectable AP-2. When we knock down AP-2 in HeLa cells
using siRNAs, clathrin-mediated endocytosis of the trans-
ferrin receptor goes down to background levels, but clath-
rin-mediated endocytosis of the EGF receptor and of an LDL
receptor chimera (as assayed by binding the ligand to the
cell surface at 4°C and then warming the cells to 37°C) still
proceed normally, even though there are 12-fold fewer clath-
rin-coated pits at the plasma membrane (Motley et al., 2003;
see also Conner and Schmid, 2003; Hinrichsen et al., 2003;
Huang et al., 2004). Thus, it now appears that AP-2 is just
one, albeit very abundant, adaptor for clathrin-mediated
endocytosis.
Although less is known about clathrin-mediated traffick-
ing from intracellular membranes, we and others have iden-
tified a number of binding partners for the appendage do-
main of the AP-1  subunit, which are candidates for
alternative adaptors on the AP-1 pathway. One of these
proteins, which has been variously named epsinR (Hirst et
al., 2003; Mills et al., 2003), enthoprotin (Wasiak et al., 2002),
and Clint (Kalthoff et al., 2002), is a particularly promising
candidate, because it binds not only to AP-1, but also to
clathrin and to phosphoinositides. The phosphoinositide in-
teraction is mediated by the ENTH (epsin N-terminal ho-
mology) domain of epsinR, but unlike the ENTH domains of
epsins 1–3, which bind PIP2, the ENTH domain of epsinR
prefers PI(4)P, a phosphoinositide mainly generated on TGN
membranes. AP-1 also binds PI(4)P, and in both cases there
is evidence that this interaction is important for recruiting
the proteins onto the appropriate membrane (Wang et al.,
2003). Another difference between epsinR and the epsins is
that epsinR has no ubiquitin interacting motif, suggesting
that if it is indeed an adaptor, it probably does not recognize
ubiquitinated proteins but some other type of cargo. In a
Article published online ahead of print. Mol. Biol. Cell 10.1091/
mbc.E04–06–0468. Article and publication date are available at
www.molbiolcell.org/cgi/doi/10.1091/mbc.E04–06–0468.
□D The online version of this article contains supplemental material
at MBC Online (http://www.molbiolcell.org).
‡ Corresponding author. E-mail address: msr12@mole.bio.cam.ac.uk.
© 2004 by The American Society for Cell Biology 5593
recent yeast two-hybrid library screen for binding partners
for the endosomal SNARE protein, vti1b, Chidambaram et
al. (2004) isolated epsinR, and they suggested that this inter-
action might help to sort vti1b into budding vesicles.
In our previous study on AP-2, we were able to quantify
the packaging of different types of cargo into CCVs at the
plasma membrane by using ligand uptake assays (Motley et
al., 2003). However, this method cannot be used to study
intracellular trafficking, nor can it be used to monitor the
trafficking of SNAREs because most of the SNAREs have
little or no extracellular or lumenal domain. Therefore, we
have developed a method for isolating CCVs from HeLa
cells so that cargo content could be assayed in cells that were
depleted of particular coat components by RNAi. In this
way, we have been able to test the hypothesis that epsinR is
an adaptor for vti1b.
MATERIALS AND METHODS
Plasmid Construction and GST Pull-downs
Standard molecular biology techniques were used throughout this study
(Sambrook and Russell, 2001). For pull-down experiments, GST fusion pro-
teins were made with the NH2-terminal domains of epsinR (amino acids
1–166) and vti1b (amino acids 1–206) and pull-downs were carried out essen-
tially as previously described (Hirst et al., 2003), using HeLa extracts in PBS
containing 0.1% NP-40 and the protease inhibitor AEBSF, at a protein con-
centration of 1.5 mg/ml. Bound proteins were eluted with sample buffer and
subjected to SDS-PAGE. Gels were transferred onto nitrocellulose for Western
blotting.
Antibodies and Blotting
Rabbit antibodies against epsinR, AP-1 , clathrin, CI-MPR, and 1A were
raised in house and have already been described (Page et al., 1999; Hirst et al.,
2003). Monoclonal antibodies were purchased from BD Transduction Labo-
ratories (Lexington, KY; anti-vti1a, anti-vti1b, and anti-2), from Santa Cruz
Biotechnology (Santa Cruz, CA; anti-EF-2), from Sigma (St. Louis, MO; antig),
and from Qbiogene (Carlsbad, CA; anti-CD8). Western blots were probed
with these antibodies, followed by a rabbit anti-mouse linker where appro-
priate and then by 125I-protein A as previously described (Hirst et al., 2003).
Samples included GST pull-downs, whole cell extracts, and CCVs isolated
from tissue culture cells. Quantifications were carried out using a Packard
Cyclone phosphorimager (Meriden, CT).
Microscopy
For immunofluorescence, HeLa cells were fixed with 3% paraformaldehyde,
followed by permeabilization with 0.1% Triton X-100. The CD8-furin–ex-
pressing cell line was a gift from Matthew Seaman (CIMR, University of
Cambridge, United Kingdom; Seaman, 2004). Primary antibodies are listed
above; secondary antibodies were purchased from Molecular Probes (Eugene,
OR). Cells were viewed using a Zeiss Axiophot fluorescence microscope
(Thornwood, NY) equipped with a CCD camera (Princeton Instruments,
Princeton, NJ) and photographs were recorded using IP Labs software (Scana-
lytics, Fairfax, VA). The GFP-conjugated clathrin light-chain construct was a
kind gift of Stephen Royle (MRC Laboratory of Molecular Biology). Transfec-
tions with this construct were carried out using Fugene (Roche Diagnostics,
Lewes, East Sussex, United Kingdom) according to the manufacturer’s in-
structions, and specimens were viewed without fixation.
For electron microscopy, control and siRNA-treated HeLa cells were pre-
pared as previously described (Motley et al., 2003) and observed in a Philips
CM100 transmission electron microscope (Mahwah, NJ). For morphometric
analyses, electron micrographs were taken of the Golgi region of control,
epsinR-depleted, and 1-depleted cells. To choose the regions to be photo-
graphed in an unbiased way, Golgi stacks were found at low magnification,
under conditions where clathrin-coated buds and vesicles could not be re-
solved (7,900) and then photographed at higher magnification (39,000).
Two measurements were made. First, individual clathrin-coated budding
profiles within 1 m of a Golgi stack were counted in 20 micrographs for each
of the three conditions. Second, the diameters of 25 clathrin-coated budding
profiles that had been caught in cross section were measured using analySIS
3.0 image analytical software (Soft Imaging System, Lakewood, CO).
RNA Interference
siRNA duplexes against conserved sequences of the target cDNAs were
purchased from Dharmacon (Boulder, CO). An epsinR sequence, AAC-
CAUUGAUCUUGGAGCAGC, which had previously been found to be inef-
fective for knockdown experiments (Hirst et al., 2003), was used as a control.
For epsinR knockdowns, a new siRNA with the sequence AAUACA-
GAUAUGGUCCAGAAA was found to be more effective than the one used in
our previous article (Hirst et al., 2003). siRNAs against clathrin and 1A have
been described (Hirst et al., 2003; Motley et al., 2003). HeLa cells were trans-
fected using Oligofectamine (Invitrogen, Carlsbad, CA) as specified by the
manufacturer. For efficient knockdown two transfections were performed 2 d
apart, and experiments were carried out 2 d after the second knockdown.
CCV Isolation
CCVs were isolated from HeLa cells growing on six to eight 9-cm2 tissue
culture dishes (for small-scale preparations) or on four 500-cm2 tissue culture
dishes (for large-scale preparations). The cells were rinsed briefly with ice-
cold PBS followed by ice-cold buffer A (0.1 M MES, pH 6.5, 0.2 mM EGTA, 0.5
mM MgCl2, 0.02% NaN3, 0.2 mM PMSF) and then scraped with a sliced
rubber stopper into either 1 ml buffer A per dish (small scale) or 5 ml
buffer A per dish (large scale). Homogenization was carried out using 15
strokes of a motorized Potter glass homogenizer. Other methods of homog-
enization, e.g., using a ball-bearing homogenizer or a sonicator, did not
significantly improve the yield or purity of the CCVs. The homogenates were
centrifuged in a Beckman S4180 rotor (Fullerton, CA) at 4800 rpm for 32 min,
after which the supernatant was treated with 50 mg/ml RNase A (MP
Biomedicals, Orangebay, NJ) for 30 min at 4°C. The membranes were pelleted
by spinning at 50,000 rpm for 30 min in a Beckman TLA100.4 rotor and then
resuspended in 300 l-1 ml buffer A using a 1-ml hand-held glass homoge-
nizer. The suspension was mixed with an equal volume of 12.5% Ficoll/12.5%
sucrose in buffer A and centrifuged in a TLA100.4 rotor at 20,000 rpm for 25
min. The supernatant was diluted with four volumes of buffer A, and the
CCVs were pelleted by spinning in a TLA100.4 rotor at 50,000 rpm for 30 min.
The pellets were resuspended in 30–100 l buffer A using a 0.1-ml hand-held
glass homogenizer. Yield was determined by quantifying the volume and
protein concentration at each step and then probing Western blots of equal
protein loadings of the various fractions with anticlathrin heavy chain fol-
lowed by 125I-protein A and measuring the bound radioactivity using a
phosphorimager.
Further purification of the CCVs was achieved by sucrose density gradient
centrifugation. A step gradient of 40, 43, 46, 49, 52, 55, and 60% sucrose in
buffer A (400 l each) was prepared, and the resuspended pellet from a large
scale preparation was layered on the top. The sample was centrifuged for 2 h
at 52,000 rpm in a Beckman SW55 Ti rotor, and 200-l fractions were collected
from the top. The fractions were diluted with five volumes of buffer A,
pelleted by spinning in a TLA100.4 rotor at 50,000 rpm for 30 min, and
resuspended in 75 l buffer A using a 0.1-ml hand-held glass homogenizer.
The fractions were assayed by SDS-PAGE followed by MALDI-TOF mass
spectrometry, by Western blotting, by fluorescence microscopy, and by elec-
tron microscopy of negatively stained preparations.
RESULTS
Morphology of the epsinR-depleted Cells
We have previously shown that we can deplete epsinR to
15% of normal levels by RNAi in both HeLa and COS cells
without impairing the sorting of the lysosomal enzyme ca-
thepsin D, although knocking down AP-1 caused cathepsin
D to be secreted (Hirst et al., 2003; see also Supplementary
Figure 1). However, if epsinR is a cargo-selective adaptor,
then we would expect that knocking it down would cause
vti1b to be missorted without necessarily affecting the traf-
ficking of other proteins. To optimize our knockdowns, we
have now synthesized a different epsinR siRNA, because the
original one was somewhat toxic, and we have also modified
our procedure so that the cells are now treated twice over a
period of 5 d. In this way we are able to deplete epsinR to
levels that are undetectable by both immunofluorescence
and Western blotting, with nearly 100% of the cells affected
(see Figures 1d, 2, and 7).
By electron microscopy, the epsinR-depleted cells look
essentially normal (Figure 1a), unlike clathrin-depleted cells,
which have swollen post-Golgi membrane compartments
and no detectable clathrin-coated buds or vesicles (Motley et
al., 2003). AP-1–depleted cells also have a normal post-Golgi
morphology (Figure 1b), and clathrin-coated membranes
can be seen in the Golgi region in both epsinR and AP-1
knockdowns (arrowheads). However, we could detect some
subtle differences between the siRNA-treated cells and con-
trols (Figure 1c and Table 1). The number of clathrin-coated
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Figure 1. Morphology of control and siRNA-treated cells. (a–c) Electron micrographs of epsinR-depleted (a), AP-1–depleted (b), and control
cells (c). In both knockdowns, the overall morphology of the Golgi region looks normal and clathrin-coated budding profiles (arrowheads)
can be seen. Morphometric analyses are shown in Table 1. Scale bar, 200 nm. (d and e) A mixture of control and epsinR-depleted cells was
double-labeled for epsinR (d) and AP-1 (e). Perinuclear labeling of AP-1 is more pronounced in the epsinR-depleted cells. Scale bar, 10 m.
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Figure 2. Effects of knockdown on the steady state distribution of vti1b and vti1a. (a–d) Mixtures of control and epsinR-depleted cells were
double-labeled for epsinR (a) and vti1b (b) or for epsinR (c) and vti1a (d). Both vti1 isoforms redistribute to the cell periphery in the
epsinR-depleted cells. (e–h) Mixtures of control and 1-depleted cells were double-labeled for the AP-1  subunit (e) and vti1b (f) or for the
AP-1  subunit (g) and vti1a (h). Again, both vti1 isoforms redistribute to the cell periphery in the knockdown cells. Scale bar, 10 m.
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budding profiles in the vicinity of the Golgi stack is in-
creased by 50% in the cells that lack epsinR and is de-
creased by 50% in the cells that lack 1. In addition, in the
cells that lack epsinR, the mean diameter of these profiles is
50% larger. This apparent increase in the amount of coat-
ing of TGN and post-TGN membrane in the cells that lack
epsinR could also be seen by immunofluorescence. Figure 1,
d and e, shows that AP-1 labeling in the Golgi region is more
pronounced in the epsinR-depleted cells than in controls.
Nevertheless, we saw no gross changes in the appearance of
the epsinR-depleted cells (see also Figure 3c), suggesting
that the enlarged perinuclear compartments seen by light
microscopy in cells overexpressing epsinR (Mills et al., 2003;
Saint-Pol et al., 2004) may be indirect effects of overexpres-
sion rather than direct consequences of interfering with
epsinR’s normal function.
Localization of Cargo Proteins in siRNA-treated Cells
To investigate the effect of epsinR depletion on the steady
state distribution of vti1b, we double-labeled mixtures of
control and siRNA-treated cells with antibodies against
epsinR and vti1b. Figure 2, a and b, shows that in untreated
cells vti1b (b) has a strongly perinuclear distribution, similar
although not identical to that of epsinR (a). In the cells that
lack epsinR, the vti1b labeling is much more scattered, al-
though by Western blotting the total amount of vti1b was
found to be unchanged (see Figure 7a). We also examined
the effect of epsinR depletion on vti1a, which is 33% identi-
cal to vti1b, but which is unable to bind to epsinR in vitro or
in the yeast two-hybrid system (Chidambaram et al., 2004).
Surprisingly, we found that knocking down epsinR had a
similar effect on the distribution of vti1a (Figure 2, c and d).
In addition, when we knocked down the 1 subunit of the
AP-1 adaptor complex, we also saw a redistribution of both
vti1b and vti1a away from the perinuclear region (Figure 2,
e–h). These results indicate either that both vti1 isoforms
interact with both epsinR and AP-1, or alternatively that at
least some of the effects of knockdown on the steady state
distribution of vti1b and vti1a may be indirect.
We also looked at the effects of epsinR and AP-1 knock-
down on other membrane proteins that are known to cycle
between the TGN and endosomes in a clathrin-dependent
manner. We saw a striking redistribution of a CD8-furin
chimera in AP-1–depleted cells. Normally this construct
resides mainly in the TGN (Figure 3a; see also Seaman,
2004), but in the absence of AP-1, much of it is found in
peripheral vesicles and at the plasma membrane (Figure 3b).
Table 1. Morphometric analyses of clathrin-coated budding profiles
in control and siRNA-treated cells
Control
EpsinR
knockdown
1
knockdown
Frequency
(per Golgi stack)
1.06 1.56 0.5
Mean diameter
(nm) (SD)
63.95  10.47 94.61  16.83 70.51  10.41
Electron micrographs were taken of the Golgi region of control,
epsinR-depleted, and 1-depleted cells. To determine the frequency
of clathrin-coated budding profiles, individual profiles within 1 m
of a Golgi stack were counted in 20 micrographs for each of the three
conditions. The numbers were as follows: for the control cells, 35
profiles and 33 stacks; for the epsinR-depleted cells, 39 profiles and
25 stacks; and for the 1-depleted cells, 15 profiles and 30 stacks. To
determine the mean diameters of the clathrin-coated budding pro-
files, 25 profiles that had been caught in cross section were mea-
sured for each of the three conditions.
Figure 3. Effects of knockdown on the steady state distribution of
a CD8-furin chimera. In control cells (a), the chimera is localized
mainly to the TGN. In 1-depleted cells (b), it redistributes to more
peripheral membranes and to the cell surface. However, in epsinR-
depleted cells (c), its localization is unchanged. Scale bar, 10 m.
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In contrast, epsinR depletion had no apparent effect on the
localization of the CD8-furin chimera (Figure 3c). The local-
ization of TGN46 and of the cation-independent mannose
6-phosphate receptor were also found to be unaffected by
epsinR knockdown (unpublished results). Thus, so far we
have only been able to detect an effect of epsinR depletion on
the steady state distribution of vti1b and vti1a.
Because previous binding studies on epsinR, vti1b, and
vti1a had been done using entirely recombinant proteins
(Chidambaram et al., 2004), we could not rule out the pos-
sibility that interactions that occur in the context of the
whole cell might have been missed. Therefore, we used a
GST-epsinR construct to pull down binding partners from
HeLa cell extracts, then probed with antibodies against ei-
ther vti1b or vti1a. Figure 4 shows that under these condi-
tions, only vti1b comes down with epsinR. We also did
pull-downs using a GST-vti1b construct, then probed with
antibodies against either epsinR or AP-1, but we were only
able to detect epsinR (Figure 4). Thus, there is a discrepancy
between the data shown in Figures 2 and 4. Knocking down
either epsinR or AP-1 strongly affects the steady state dis-
tribution of both vti1b and vti1a, yet we can only detect an
interaction in vitro between epsinR and vti1b.
Isolation of CCVs from HeLa Cells
Because the steady state distribution of a membrane protein
can be influenced by more than one trafficking pathway and
by more than one protein-protein interaction, we needed a
more direct assay for determining whether epsinR or AP-1
knockdown was preventing either vti1b or vti1a from get-
ting packaged into CCVs. Therefore, we decided to develop
a method for isolating CCVs from HeLa cells, either with or
without first treating the cells with siRNAs.
One advantage of using cultured cells is that they can be
experimentally manipulated, and we were able to exploit
this by using HeLa cells that had been transiently trans-
fected with GFP coupled to clathrin light chain to monitor
the release of CCVs after cell breakage. Figure 5a shows that
after disrupting the cells (either by homogenization or by
sonication), many clathrin-coated spots remained associated
with membrane fragments, and by Western blotting (Figure
5b) we found that 50% of the total clathrin came down in
the first low-speed spin and had to be discarded. Most of the
remaining clathrin was soluble and remained in the super-
natant when centrifuged at high speed. After resuspending
the high-speed pellet and centrifuging at moderate speed in
a Ficoll/sucrose solution to remove the remaining larger
particles, we were able to isolate a CCV-enriched fraction
that contained 1% of the total clathrin from the starting
material (Figure 5b, lane 4). This low yield presumably
reflects the situation in the intact cell, where free CCVs are
relatively scarce compared with coated buds still attached to
membranes and nonassembled clathrin.
The CCVs could be further purified by sucrose density
gradient centrifugation (Figure 5, c–f), which effectively sep-
arated them from smooth membranes (Figure 5g) and gly-
cogen particles (Figure 5h) and partially separated them
from ribosomes (Figure 5c). However, this was at the ex-
pense of yield and only 20% of the clathrin added to the
gradient could be recovered, possibly because many of the
vesicles lost their coats during the procedure. Western blots
of the gradient fractions (Figure 5d) showed that clathrin,
AP-1, AP-2, and epsinR all had essentially identical profiles,
whereas vesicle cargo proteins including the cation-inde-
pendent mannose-6 phosphate receptor, vti1a, and vti1b all
fractionated as two peaks, one at the light end of the gradi-
ent with the uncoated membranes and one in the middle of
the gradient with clathrin and the other coat proteins.
We next examined the effect of knocking down clathrin
heavy chain on the composition of the “CCV-enriched”
preparation (i.e., after the Ficoll/sucrose step but without
the gradient). Because there is little or no detectable clathrin
left in these cells, this preparation should still contain con-
taminants, but it should be devoid of CCVs. Figure 6 shows
that although Coomassie blue–stained gels of the prepara-
tion do not look strikingly different in the clathrin-depleted
cells when compared with controls, by Western blotting
there are no detectable coat proteins after clathrin knock-
down (see also Figure 7b). With the exception of clathrin,
these proteins are still expressed at normal levels (Figure 7a),
so this indicates that without clathrin they fractionate dif-
ferently because they cannot be incorporated into vesicles.
Surprisingly, cargo proteins including the cation-indepen-
dent mannose 6-phosphate receptor, vti1a, and vti1b are also
reduced to very low levels in the preparation after clathrin
knockdown (Figure 6; see also Figure 7b), even though by
sucrose gradient fractionation 50% of the cargo proteins
are associated with smooth membranes (see Figure 5d). This
suggests that the smooth vesicles containing the cargo are
mainly derived from CCVs, which became uncoated either
during the preparation or inside the cell.
CCVs from epsinR-depleted Cells
Having established that clathrin knockdown reduces the
amount of both vti1b and vti1a to very low levels in the
Figure 4. GST pull-downs from HeLa cell extracts. Cell extracts
were incubated with either a GST-epsinR construct or a GST-vti1b
construct, and binding partners were pulled down with glutathio-
ne-Sepharose. The lefthand lane contains the starting material; the
other lanes contain the material that was pulled down. Western
blots were probed with anti-vti1b, anti-vti1a, anti-epsinR, and anti-
AP-1 ( subunit). The epsinR band is indicated with an arrowhead;
the band indicated with an asterisk is the GST-vti1b construct,
which cross-reacts with the antibody because it was raised against
GST-epsinR. The only interaction we can detect in the pull-downs is
between epsinR and vti1b.
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Figure 5. Isolation of CCVs from HeLa cells. (a) Cells expressing GFP-clathrin light chain were disrupted by homogenization. Many clathrin
dots remain associated with membrane fragments. Scale bar, 10 m. (b) Coomassie blue–stained gel and Western blot of equal protein
loadings of fractions from the isolation procedure. Lane 1, total cell homogenate. Lane 2, low-speed supernatant. Lane 3, high-speed pellet.
Lane 4, Ficoll/sucrose-enriched preparation. The position of the band containing clathrin heavy chain (which also contains glycogen
debranching enzyme) is indicated. (c) Coomassie blue–stained gel of the Ficoll/sucrose-enriched preparation (F/S) and fractions from a sucrose
density gradient. The indicated bands were excised and identified by mass spectrometry as clathrin heavy chain (1), 1 (2), glycogen synthase (3),
tripeptidyl peptidase (4), EF-2 (associated with ribosomes) (5), and ribosomal proteins (6). (d) Western blot of the samples shown in c, probed with
antibodies against clathrin heavy chain (CHC), the AP-1  and AP-2 2 subunits, epsinR, the cation-independent mannose 6-phosphate receptor
(CI-MPR), vti1a, and vti1b. (e) Fluorescence micrograph of fraction 5, containing GFP-labeled clathrin-coated vesicles. Scale bar, 10 m. (f–h)
Electron micrographs of negatively stained samples from the sucrose gradient: fraction 5, containing clathrin-coated vesicles (f); fraction 1,
containing smooth membranes (g); and pooled fractions from the bottom of the gradient, containing glycogen particles (h). Scale bar, 500 nm.
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fraction normally containing CCVs, we repeated the proce-
dure on control cells, cells depleted of clathrin, cells depleted
of the 1 subunit of AP-1, and cells depleted of epsinR.
Western blots of equal protein loadings of total cell homog-
enates and of the CCV-enriched fraction were then probed
with antibodies against all of these proteins as well as with
antibodies against vti1b and vti1a. Figure 7a shows that in
every case, the cell homogenates contained either undetect-
able levels or 5% of normal levels of the protein that was
knocked down, with little or no effect on the other proteins.
Figure 7b shows the CCV-enriched preparation probed
with the same antibodies. Knocking down either 1 or
epsinR does not significantly affect the amount of clathrin
recovered in this fraction, although (as also shown in Figure
6) the signal from the clathrin heavy-chain band goes down
to 5% of control when it is itself knocked down. 1 and
epsinR go down to a similar extent in the CCV-enriched
fraction when clathrin is depleted as well as when they are
themselves depleted. In addition, knocking down epsinR
caused a 50% reduction in the amount of 1 in the CCV-
enriched fraction, and knocking down 1 caused a 50%
reduction in the amount of epsinR. This suggests that the
two proteins are to some extent dependent on each other for
incorporation into the coat.
When the blots were probed with anti-vti1b, the signal
after epsinR depletion was down to 16.6  3.4% of control
levels, thus approaching the background level seen after
clathrin depletion (6.4  2.7% of control). The signal for
vti1b in the CCV preparation was also strongly reduced
after 1 depletion, to 23.2  3.0% of control. Because AP-1
depletion reduces the amount of epsinR associated with the
CCVs and vice versa, it is difficult to dissociate the effects of
the two knockdowns. Thus, it is possible that the effect of 1
depletion on the amount of vti1b in CCVs may be indirect,
mediated by epsinR. As a control, we also analyzed CCV
preparations from cells depleted of the 2 subunit of AP-2
and saw no effect on vti1b (Supplementary Figure 2).
In contrast to vti1b, vti1a is only slightly reduced in the
CCVs after 1 depletion (82.9  5.1%, as compared with
20.3  4.8% in the clathrin-depleted cells), and it is not
significantly reduced after epsinR depletion (99.1  8.0%).
This indicates that vti1a is still getting packaged efficiently
into CCVs even in the absence of any detectable AP-1 or
epsinR. Thus, neither epsinR nor AP-1 appears to act as an
essential cargo adaptor for vti1a.
DISCUSSION
We have used a novel method to investigate the role of three
different coat components, clathrin, AP-1, and epsinR, in
CCV formation and cargo selection. CCVs were isolated
from control and siRNA-treated cells, and the protein com-
position of the preparations was compared by Western blot-
ting. We found that clathrin knockdown caused every coat
protein we tested to be depleted to 5% of control levels.
With the exception of clathrin, these proteins are still ex-
pressed normally, and they are also still associated with
membranes (unpublished observations), so their loss from
the preparation indicates that without clathrin they cannot
be incorporated into vesicles. Cargo proteins were also de-
pleted from the preparation, although less severely: typi-
cally they went down to 20% of control levels. Thus,
clathrin knockdowns can be used as a baseline when exam-
ining the effects of knocking down other coat components on
CCV composition.
We found that AP-1 depletion caused a50% reduction in
the amount of epsinR associated with CCVs. This is consis-
tent with our EM observations, which showed that there
were only about half the number of clathrin-coated budding
profiles in the Golgi region in AP-1–depleted cells when
compared with controls. The remaining clathrin-coated
buds are presumably nucleated by other intracellular clath-
rin adaptors, including epsinR, which we have previously
shown can be recruited onto membranes in an AP-1–inde-
pendent manner (Hirst et al., 2003). Thus, the AP-1 knock-
down phenotype is similar in this regard to the AP-2 knock-
down phenotype. AP-2 depletion using siRNA causes a
reduction in the number of clathrin-coated pits at the plasma
membrane, but it does not completely abolish their forma-
tion, and the remaining coated pits are still positive for
alternative endocytic adaptors, such as epsin 1 (Motley et al.,
2003). Somewhat surprisingly, depleting AP-1 did not cause
any apparent decrease in the amount of clathrin we recov-
ered. This suggests that, even though AP-1 is the major
adaptor in our preparations, other less abundant adaptors
are able to facilitate CCV formation so that the final yield is
not affected.
We also found that epsinR depletion caused an 50%
reduction in the amount of AP-1 associated with CCVs. This
is more difficult to explain than the effect of AP-1 depletion
on epsinR, especially because electron micrographs indicate
Figure 6. CCVs isolated from control and clathrin-depleted cells.
The Coomassie blue–stained gel shows that all of contaminants are
still present after clathrin knockdown. The bands containing clath-
rin heavy chain and 1 (identified by mass spectrometry) are indi-
cated with a circle and a triangle, respectively. On the Western blots,
there is little or no signal in the clathrin knockdown lane for either
coat proteins (e.g., clathrin heavy chain) or cargo proteins (e.g., the
CI-MPR), whereas contaminants (e.g., EF-2) are still present.
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that there are actually more clathrin-coated budding profiles
in the Golgi region in epsinR-depleted cells than in controls.
However, we found that the mean diameter of the buds was
larger in these cells, suggesting that there may be a block in
the formation of free coated vesicles. Epsin 1 has been pro-
posed to play a role in membrane curvature (Ford et al.,
2002), and the same may be true for epsinR. Another possi-
bility is that loss of epsinR, which is the major  ear binding
partner in CCVs (Hirst et al., 2003), may cause an increase in
the relative amounts of other  ear partners at sites of
CCV formation, and this might in turn lead to changes in
vesicle invagination and/or scission. In any case, the
epsinR knockdown phenotype is clearly very different
from the phenotype described for epsinR-overexpressing
cells, which have an enlarged TGN compartment, mislo-
calization of TGN46 and of the cation-independent man-
nose 6-phosphate receptor, and increased secretion of ca-
thepsin D (Mills et al., 2003; Saint-Pol et al., 2004). This
may be because overexpression of epsinR can lead to
indirect effects that are unrelated to epsinR function. For
instance, there may be sequestration of some of epsinR’s
binding partners, such as AP-1 and clathrin.
When we assayed for vti1b in CCVs isolated from epsinR-
depleted cells, we found that it was reduced nearly to back-
ground levels. This observation provides in vivo evidence to
support the hypothesis that epsinR is a cargo adaptor for
vti1b, which was originally proposed on the basis of its
ability to bind to vti1b in vitro. Further evidence comes from
our observation that epsinR depletion alters the steady state
distribution of vti1b, causing it to move away from the Golgi
region toward the cell periphery. EpsinR has recently been
implicated in the retrograde trafficking of internalized Shiga
toxin (Saint-Pol et al., 2004), and the same may be true for
vti1b. Although vti1b has been implicated mainly in fusion
events involving late endosomes, it must be returned to
earlier compartments to be incorporated into outgoing ves-
icles, and this may be a function of epsinR.
Although the effects of epsinR depletion on vti1b are
entirely consistent with its proposed role as a vti1b-selec-
tive adaptor, two of our other observations are more
difficult to explain. First, AP-1 depletion has an effect very
similar to epsinR depletion on vti1b, yet there is no evi-
dence from our pull-down experiments for an interaction
between AP-1 and vti1b. One possibility is that such an
interaction exists but it has not yet been detected. The
interaction would not even have to be direct; normally
vti1b is associated with other SNAREs (syntaxin 7, syn-
taxin 8, and—in the complete v-/t-SNARE complex
—VAMP-8), so AP-1 could be an adaptor for one of these
other proteins. Alternatively, AP-1 may be interfering
with vti1b trafficking through its effects on epsinR. De-
pleting AP-1 causes an 50% reduction in the amount of
epsinR associated with isolated CCVs, and although AP-1
depletion has a more profound effect on the amount of
Figure 7. Effect of AP-1 and epsinR knockdown on the composition of the CCVs. a, Western blots of homogenates of control and
siRNA-treated cells show that the knockdowns are specific. (b) Western blots of the CCV preparation from the cells shown in a were probed
with the indicated antibody. The bar graph shows phosphorimager data pooled from 4–6 independent experiments, SE. Both epsinR and
AP-1 knockdowns greatly reduce the amount of vti1b in the preparation, with little or no effect on the amount of vti1a.
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vti1b in CCVs, it is possible that relatively small changes
in epsinR concentration may lead to larger changes in
vti1b concentration. We are now in the process of map-
ping the epsinR-binding site on vti1b, with the aim of
introducing mutated constructs into HeLa cells. If we can
show that epsinR-binding mutants are no longer incorpo-
rated into CCVs, this should help us to dissociate the
requirements for epsinR and AP-1 in vti1b sorting.
The second puzzling observation is our finding that
epsinR and AP-1 knockdowns alter the steady state dis-
tribution of vti1a as well as vti1b. Unlike vti1b, vti1a has
not been demonstrated to interact with either epsinR or
AP-1, and moreover it is not lost from CCVs when either
epsinR or AP-1 is knocked down. Thus, there must be
other cargo adaptors for vti1a, which can still package it
into CCVs even when its subcellular distribution is al-
tered. Why then would epsinR and AP-1 knockdown
cause vti1a to redistribute? Possibly there may be changes
in the localization of the entire vti1a-containing compart-
ment. Knocking down either epsinR or AP-1 prevents
vti1b from being packaged into CCVs and changes its
steady state distribution, and once a SNARE gets mislo-
calized there may be a number of knock-on effects. How-
ever, not all of the proteins that cycle between the TGN
and endosomes are affected by epsinR knockdown. For
instance, we have shown that a CD8-furin chimera gets
mislocalized in AP-1– depleted cells, but its distribution is
normal in epsinR-depleted cells.
It is clear from all of these experiments that knocking
down a coat component and then looking for changes in the
steady state distribution of potential cargo proteins can
sometimes give misleading information and that more direct
assays are needed for adaptor function. The CCV isolation
procedure is one such assay, and it can potentially be used
to investigate the role of any CCV protein in cargo selection.
In addition to epsinR, there are a number of other  ear
binding partners whose function is still unknown, including
-synergin (Page et al., 1999), p200 (Hirst et al., 2003), aft-
iphilin, and NECAP (Mattera et al., 2004), and these are all
candidates for alternative adaptors on the AP-1 pathway.
There are also several  ear binding partners whose function
is not entirely clear, and these may be alternative adaptors
on the AP-2 pathway (Traub, 2003). In some cases, it is
possible to make educated guesses about what the cargo
proteins might be, and here it will be possible to use Western
blotting to quantify these proteins in CCVs after siRNA
knockdown, as we have done in the present study. For other
candidate adaptors, an unbiased proteomics approach may
be the best way forward. We have recently begun a system-
atic analysis of the protein composition of HeLa cell CCVs,
comparing preparations from control and clathrin-depleted
cells. This enables us to distinguish bona fide components
from contaminants, which is always a problem when trying
to establish the proteome of an organelle. By using the same
approach of treating cells with an siRNA and then carrying
out a comparative proteomics analysis on their CCVs, we
hope to be able to establish the functions of even very minor
adaptors, because when they are knocked down, their cargo
proteins should be depleted from the preparation as well.
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